The Technical Analyst
Select Language :
Eton Pharmaceuticals Inc [ETON]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Eton Pharmaceuticals Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Eton Pharmaceuticals Inc is listed at the  Exchange

-1.32% $3.75

America/New_York / 28 mar 2024 @ 16:00


Eton Pharmaceuticals Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 96.20 mill
EPS: -0.0100
P/E: -375.00
Earnings Date: Nov 13, 2023
SharesOutstanding: 25.65 mill
Avg Daily Volume: 0.0719 mill
RATING 2024-03-28
A-
Buy
RATINGS
Rating CashFlow: Buy
Return On Equity: Neutral
Return On Asset: Neutral
DE: Buy
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -375.00 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-63.79x
Company: PE -375.00 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 3.56 - 3.94

( +/- 5.15%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-02-13 Gruber James R. Buy 144 677 Stock Option (Right to buy)
2024-02-13 Adams Jennifer Mckie Buy 30 000 Stock Option (Right to buy)
2024-02-13 Brynjelsen Sean Buy 438 633 Stock Option (Right to buy)
2024-02-13 Casamento Charles J Buy 30 000 Stock Option (Right to buy)
2024-02-13 Krempa David Buy 144 677 Stock Option (Right to buy)
INSIDER POWER
53.82
Last 96 transactions
Buy: 4 266 352 | Sell: 3 981 653

Forecast: 16:00 - $3.75

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $3.75
Forecast 2: 16:00 - $3.75
Forecast 3: 16:00 - $3.75
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $3.75 (-1.32% )
Volume 0.0557 mill
Avg. Vol. 0.0719 mill
% of Avg. Vol 77.39 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Eton Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Eton Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Eton Pharmaceuticals Inc

Last 10 Buy & Sell Signals For ETON

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Eton Pharmaceuticals Inc

ETON

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Last 10 Buy Signals

Date Signal @
RADUSDMar 29 - 08:24$3.39
XVSUSDMar 29 - 08:20$16.04
SAVAXUSDMar 29 - 08:1961.03
RSS3USDMar 29 - 08:190.550
STETHUSDMar 29 - 08:193 528.46
P2PSUSDMar 29 - 08:18202.45
NAKAUSDMar 29 - 08:192.12
MNTUSDMar 29 - 08:191.160
KASUSDMar 29 - 08:200.137
JOEUSDMar 29 - 08:190.872

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.